Pure Global

“CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter - Taiwan Registration 5d80df078005d888e1d2c98e97376400

Access comprehensive regulatory information for “CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5d80df078005d888e1d2c98e97376400 and manufactured by CID S.P.A.. The authorized representative in Taiwan is CHAICO INVESTMENT CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5d80df078005d888e1d2c98e97376400
Registration Details
Taiwan FDA Registration: 5d80df078005d888e1d2c98e97376400
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter
TW: “希艾迪” 擴立安依芙雷帕黴素冠狀動脈塗藥支架
Risk Class 3
MD

Registration Details

5d80df078005d888e1d2c98e97376400

Ministry of Health Medical Device Import No. 035007

DHA05603500700

Company Information

Italy

Product Details

Details are as detailed as approved Chinese instructions

E Cardiovascular devices

E0001 Cardiovascular stents

Imports outside the borders;; Safety monitoring

Dates and Status

Oct 25, 2021

Oct 25, 2026